YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Krebs Biochem
Krebs Biochem
BSE: 524518NSE: KREBSBIOISIN: INE268B01013

29th-Nov-2021 17:45Source: BSE

Krebs Biochemicals & Industries - OUTCOME OF THE EXTRA-ORDINARY GENERAL MEETING HELD ON MONDAY, THE 29TH NOVEMBER, 2021

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, please find enclosed the summary of proceedings of the Extra Ordinary General Meeting (EGM) of the Company held on Monday, November 29 2021 through Video Conference / Other Audio-Visual Means.

Further Mrs. Krithika Sharma, Practicing Company Secretary is the Scrutinizer for the remote e- voting and voting process carried out at the EGM.

The voting results on the resolutions shall be declared on or before 1st December, 2021, along with scrutinizer's report and the same shall be placed on the Company's website at www.krebsbiochem.com and on the website of Kfintech Technologies Private Limited at www.kfintech.com and shall also be communicated to the Stock Exchanges where the shares of the Company are listed.

Sections